SRRK (Scholar Rock Holding Corporation) Stock Financials & Earnings

SRRKScholar Rock Holding Corporation

Mkt Cap$5B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$378M

EPS (TTM)-$3.29

Free Cash Flow (TTM)-$301M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	-$3M	-$41M
Q2 23	$0	-$3M	-$39M
Q3 23	$0	-$708K	-$44M
Q4 23	$0	-$672K	-$48M
Q1 24	$0	-$598K	-$58M
Q2 24	$0	-$498K	-$59M
Q3 24	$0	-$446K	-$65M
Q4 24	$0	-$395K	-$69M
Q1 25	$0	-$393K	-$77M
Q2 25	$0	-$417K	-$112M
Q3 25	$0	-$423K	-$104M
Q4 25	$0	$1M	-$92M

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$27M	—	$11M
Q2 23	$24M	—	$12M
Q3 23	$30M	$13M	—
Q4 23	$34M	—	$13M
Q1 24	$42M	$15M	—
Q2 24	$42M	—	$17M
Q3 24	$48M	—	$16M
Q4 24	$50M	—	$19M
Q1 25	$48M	—	$28M
Q2 25	$62M	$50M	—
Q3 25	$50M	—	$53M
Q4 25	$48M	$126M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$151M	$124M	$275M
Q2 23	$108M	$141M	$249M
Q3 23	$68M	$151M	$219M
Q4 23	$102M	$178M	$280M
Q1 24	$92M	$146M	$238M
Q2 24	$93M	$97M	$190M
Q3 24	$76M	$63M	$139M
Q4 24	$178M	$259M	$437M
Q1 25	$138M	$226M	$364M
Q2 25	$153M	$142M	$295M
Q3 25	$287M	$83M	$370M
Q4 25	$324M	$44M	$368M

Shares Outstanding

Revenue Per Employee

Revenue / Employee